AccessGUDID - DEVICE: Durette #4, PMMA (20 mm, 3.5 cc) (M8721242003)

GUDID

Device Identifier (DI) Information

Brand Name: Durette #4, PMMA (20 mm, 3.5 cc)
Version or Model: 12-420
Commercial Distribution Status: Not in Commercial Distribution
Catalog Number:
Company Name: Oculo-Plastik Inc

Primary DI Number: M8721242003
Issuing Agency: HIBCC
Commercial Distribution End Date: September 01, 2020
Device Count: 1
Labeler D-U-N-S® Number*: 257382580 *Terms of Use

Device Description: The Durette® ocular implant, made of clear acrylic material (PMMA), is a smooth-surface motility implant used for enucleation, evisceration, and secondary implantation. There are two 20 mm diameter models that are quasi-spherical: Model I, which has a slightly flattened smooth anterior surface (1 mm flatter vs. a sphere); and Model IV, which has four pronounced mounds (within the sphere) for optimal coupling and motility. The implants have a network of 20 interconnected tunnels (1 to 2 mm) offering the eye surgeon with 3 levels for suturing each rectus muscle, and allowing new tissue to form and integrate with surrounding tissue, while aiming to prevent migration, forward displacement and tissue stretching. They both have an off-center medial posterior elongation for added volume and better front positioning of details for coupling with ocular prostheses.

Device Characteristics

What MRI safety information does the labeling contain?	Labeling does not contain MRI Safety Information
Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437):	No
Device labeled as "Not made with natural rubber latex":	No
For Single-Use:	Yes
Prescription Use (Rx):	Yes
Over the Counter (OTC):	No
Kit:	No
Combination Product:	No
Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P):	No

GMDN

[?]

GMDN Term Code	GMDN Term Name	GMDN Term Definition	GMDN Term Status [?]	Implantable?
46902	Orbital sphere implant	An implantable ocular device designed to permanently fill the orbital cavity following enucleation, evisceration, or after the removal of another ocular implant (used as a secondary implant), to replace the volume and possibly, given the surgical method, to impart motion to the eventual ocular prosthesis (the artificial eyeball). It is typically aspherical and may have porous surfaces to facilitate colonization by fibrovascular tissue to offer the advantages of reduced risk of infection or implant extrusion. It is available in various sizes and is typically made of polymethylmethacrylate (PMMA), poly 2-hydroxyethylmethacrylate (PHEMA), or silicone.	Active	true

FDA Product Code

[?]

Product Code	Product Code Name
HPZ	Implant, Eye Sphere

FDA Premarket Submission

FDA Premarket Submission Number [?]	Supplement Number [?]
Premarket Submission Number Not Available/Not Released

Device Exempt from Premarket Submission: No CLOSE

Sterilization

Device Packaged as Sterile: No
Requires Sterilization Prior to Use: Yes

Sterilization Method [?]
Ethylene Oxide

Storage and Handling

[?]

Storage and Handling
No storage/handling found

Clinically Relevant Size

[?]

Size Type Text
Total Volume: 3.5 Milliliter
Outer Diameter: 20 Millimeter

Device Record Status

Public Device Record Key: 6a47094b-55d0-47cc-b856-98e7b64d05ea
Public Version Date: March 30, 2021
Public Version Number: 4
DI Record Publish Date: October 16, 2016